ArticleVaccines2022

SARS-CoV-2 mRNA Vaccination in People with Multiple Sclerosis Treated with Fingolimod: Protective Humoral Immune Responses May Develop after the Preferred Third Shot.

Lutz Achtnichts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.